We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETM
951
DELISTED
PETSMART INC
PETM
$482K 0.03%
6,884
-4,513
-40% -$314K
AXON
952
Axon Enterprise
AXON
$49.1B
$481K 0.03%
+31,150
New +$441K
GLNG icon
953
Golar LNG
GLNG
$5.11B
$479K 0.03%
+7,220
New +$457K
MRVL icon
954
Marvell Technology
MRVL
$189B
$479K 0.03%
35,560
-245,673
-87% -$3.38M
NSC icon
955
Norfolk Southern
NSC
$76.8B
$479K 0.03%
4,291
-36,815
-90% -$3.9M
THS
956
DELISTED
Treehouse Foods
THS
$479K 0.03%
5,946
-3,472
-37% -$274K
WPZ
957
DELISTED
Williams Partners L.P.
WPZ
$479K 0.03%
7,987
-5,509
-41% -$326K
UAL icon
958
United Airlines
UAL
$43.1B
$478K 0.03%
10,219
+1,899
+23% +$88.1K
GPT
959
DELISTED
Gramercy Property Trust
GPT
$478K 0.03%
27,648
+10,700
+63% +$195K
SIMG
960
DELISTED
SILICON IMAGE INC
SIMG
$477K 0.03%
94,612
+2,900
+3% +$14.5K
TGI
961
DELISTED
Triumph Group
TGI
$476K 0.03%
+7,324
New +$490K
WLKP icon
962
Westlake Chemical Partners
WLKP
$750M
$475K 0.03%
+16,386
New +$497K
BLUE
963
DELISTED
bluebird bio
BLUE
$474K 0.02%
+1,019
New +$470K
PTEN icon
964
Patterson-UTI
PTEN
$3.62B
$474K 0.02%
14,566
-103,800
-88% -$3.53M
DNR
965
DELISTED
Denbury Resources, Inc.
DNR
$474K 0.02%
31,526
-65,928
-68% -$1.11M
ZBRA icon
966
Zebra Technologies
ZBRA
$17.6B
$473K 0.02%
6,661
+540
+9% +$42.1K
TESO
967
DELISTED
Tesco Corp
TESO
$473K 0.02%
23,820
-21,300
-47% -$438K
CROX icon
968
Crocs
CROX
$6.58B
$472K 0.02%
+37,542
New +$563K
AVNR
969
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$472K 0.02%
39,628
-12,700
-24% -$86.7K
EL icon
970
Estee Lauder
EL
$31.5B
$471K 0.02%
6,304
-22,673
-78% -$1.71M
EPAC icon
971
Enerpac Tool Group
EPAC
$1.89B
$471K 0.02%
15,427
-86
-0.6% -$2.84K
FSLR icon
972
First Solar
FSLR
$25.4B
$471K 0.02%
7,154
-1,756
-20% -$119K
SKX
973
DELISTED
Skechers
SKX
$471K 0.02%
26,487
-10,107
-28% -$185K
PRXL
974
DELISTED
Parexel International Corp
PRXL
$471K 0.02%
7,471
-4,411
-37% -$251K
CVGI icon
975
Commercial Vehicle Group
CVGI
$129M
$470K 0.02%
+75,991
New +$667K

Similar funds

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.